FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 09:16:54 23/05/2024 pm IST | ||
| 8.94 EUR | -8.12% |
|
| Current month | +11.71% | ||
| 1 month | +48.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 8.94 | -8.12% |
| 22/24/22 | 9.73 | -2.01% |
| 21/24/21 | 9.93 | -4.70% |
| 20/24/20 | 10.42 | +1.66% |
| 17/24/17 | 10.25 | -0.49% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 09:16 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BV |
| ISIN | DE000HD36BV2 |
| Date issued | 28/02/2024 |
| Strike | 150.2 $ |
| Maturity | Unlimited |
| Parity | 7.56 : 1 |
| Emission price | 10.47 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.09 € |
|---|---|
| Lowest since issue | 6.07 € |
| Spread | 0.03 € |
| Spread % | 0.34% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
